DCF — FAXTON-ST. LUKES HEALTHCARE
Enterprise Value: $-700.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-700.5M
Enterprise Value
$-218.6M
PV of Cash Flows
$-482.0M
PV of Terminal Value
$-776.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $347.4M | $-45.3M | -13.0% | $-60.0M | $-54.6M |
| Year 2 | $357.9M | $-43.1M | -12.0% | $-58.2M | $-48.1M |
| Year 3 | $368.6M | $-40.7M | -11.0% | $-56.3M | $-42.3M |
| Year 4 | $379.7M | $-40.0M | -11.0% | $-56.1M | $-38.3M |
| Year 5 | $391.1M | $-40.2M | -10.0% | $-56.8M | $-35.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-700.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$337.3M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.13540616306519035
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5